comparemela.com

Latest Breaking News On - Arbutus biopharma corp - Page 1 : comparemela.com

Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma

On May 20, 2024, Whitefort Capital Management announced that it has issued an open letter to shareholders of Arbutus Biopharma Corp, stating that it believes that the Company is most likely to.

Arbutus biopharma corpWhitefort capital managementChief scientific officer mike sofia

Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value

Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited kingdomMichaelj mcelhaughChris anzaloneJoseph kaplanFrank tortiModerna spikevaxArbutus biopharma corporationUs district courtWhitefort capital master fundRoivant sciences ltdArrowhead pharmaceuticals incArbutus biopharma corpCompany molar ratio patentsJanssen pharmaceuticals inc

Arbutus: Q1 Earnings Snapshot

WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Thursday reported a loss of $17.9 million in its first quarter.

United statesArbutus biopharma corpArbutus biopharmaEarns arbutus biopharma

Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials

ABUS Announces Decrease in Annual Revenue and Net Loss for 2023

Michaelj mcelhaughArbutus biopharma corpFinancial highlightsInterim presidentIopharmaceutical companyCash equivalentsClinical trialsArbutus biopharmaOperating expensesNet lossClinical progressCash position

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update Conference Call.

City ofUnited kingdomDavid hastingsDave hastingsMike mcelhaughBristol myers squibbMichaelj mcelhaughRoy buchananKaren simsLisa caperelliArbutus biopharma corpArbutus biopharma corporationCall transcript novemberBiopharma corporationArbutus third quarter corporateFinancial update conference

vimarsana © 2020. All Rights Reserved.